Initial effects likely reflect water weight fluctuation rather than fat loss
This synergy not only supports weight loss efforts but also optimizes overall health, which is crucial for both surgical candidates and those pursuing non-surgical cosmetic treatments
Review Your Plan's Clinical Policy Bulletins: This is a pro-level move
A key differentiator of Mardrigals resmetirom is that in a pivotal Phase 3 trial, it achieved both primary endpoints of NASH resolution and reduction in fibrosis (MAESTRO-NASH), the two liver histological improvement endpoints the FDA has proposed as reasonably likely to predict clinical benefit
A nationwide Israeli Epi-IIRN cohort of 3,737 patients with IBD and type-2 diabetes found that GLP-1 analogs lowered the composite risk of steroid dependence, hospitalization, and surgery
Given the peptide molecular weight of 5,414.9 Da and 39 amino acid sequence including non-standard residues, mass spectrometry confirmation of the correct molecular species is essential